Research
Search
Close
LIU Zhiyan
- Chief Physician, Graduate Supervisor
- Department: Pathology
- Research Area: Clinical Pathology
- Research Interests:
- Contact: zhiyanliu@shsmu.edu.cn
- Endocrine pathology and thyroid cytopathology
- Visiting Scholar, University of Michigan, USA, 2018
- MD, Ph.D from Wakayama Medical University, Japan, 2011
- MD, Ph.D from Shandong University, China, 2011
- Master from Huazhong University of Science and Technology, China, 2002
- Bachelor from Jining Medical University, China, 1999
- Director, Department of Pathology, Shanghai Sixth People's Hospital
- Vice president ,Thyroid Cancer Committee of Chinese Society of Clinical Oncology
- Committee member, Tumor Pathology Committee of Chinese Cancer Anti-Cancer Amember
- Member, Asian Thyroid Working Group
- Member, the International Academy of Cytology and American Thyroid Association
- 01/04/2023-31/03/2026
Science and Technology Innovation Plan of Science and Technology Commission of Shanghai Municipality (STCSM) , ¥200,000, 23ZR1448200
The effect and mechanism of long-term exposure of perfluorooctanoic acid (PFOA) inducing carcnoigenesis of thyroid carcinoma through peroxisome proliferators-activated receptor γ
Role: Subject leader - 01/12/2020-30/11/2024
Science and Technology Innovation Plan of Science and Technology Commission of Shanghai Municipality (STCSM) , ¥400,000, 20Z11900304
Tracing model of primary unknown tumor in bone metastatic tumor
Role: Subject leader - 01/08/2020-30/07/2023
Shanghai Sixth People's Hospital high-level talent introduction research start-up fund, ¥300,000, （20200701）
The mechanism of thyroid cancer induced by long-term exposure of decabromodi-phenyl ether (BDE-209) in indoor air
Role: Subject leader - 01/01/2020-31/12/2023
National Natural Science Foundation of China, ¥550,000, 81972500
The mechanism of long-term exposure of decabromodi-phenyl ether (BDE-209) inducing papillary thyroid carcinoma through thyroid hormone receptor β
Role: Subject leader - 00/07/2019-00/06/2022
Shandong Province nature fund surface project, ¥200,000, ZR2019MH024
The mechanism oflong-term exposure of decabromodi-phenyl ether (BDE-209) inducing thyroid carcinoma
Role: Subject leader
